Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: DCIS
Interventions: DRUG: Anastrozole
Sponsor: Rita Sanghvi, Mehta
Collaborators: AstraZeneca